全文获取类型
收费全文 | 3234篇 |
免费 | 232篇 |
国内免费 | 83篇 |
专业分类
耳鼻咽喉 | 59篇 |
儿科学 | 120篇 |
妇产科学 | 66篇 |
基础医学 | 402篇 |
口腔科学 | 64篇 |
临床医学 | 528篇 |
内科学 | 646篇 |
皮肤病学 | 66篇 |
神经病学 | 165篇 |
特种医学 | 362篇 |
外科学 | 210篇 |
综合类 | 90篇 |
一般理论 | 1篇 |
预防医学 | 285篇 |
眼科学 | 67篇 |
药学 | 250篇 |
中国医学 | 3篇 |
肿瘤学 | 165篇 |
出版年
2021年 | 37篇 |
2020年 | 20篇 |
2019年 | 43篇 |
2018年 | 45篇 |
2017年 | 42篇 |
2016年 | 38篇 |
2015年 | 44篇 |
2014年 | 67篇 |
2013年 | 107篇 |
2012年 | 102篇 |
2011年 | 92篇 |
2010年 | 92篇 |
2009年 | 82篇 |
2008年 | 97篇 |
2007年 | 146篇 |
2006年 | 116篇 |
2005年 | 104篇 |
2004年 | 105篇 |
2003年 | 70篇 |
2002年 | 97篇 |
2001年 | 98篇 |
2000年 | 85篇 |
1999年 | 85篇 |
1998年 | 120篇 |
1997年 | 103篇 |
1996年 | 123篇 |
1995年 | 97篇 |
1994年 | 106篇 |
1993年 | 91篇 |
1992年 | 67篇 |
1991年 | 76篇 |
1990年 | 74篇 |
1989年 | 73篇 |
1988年 | 69篇 |
1987年 | 74篇 |
1986年 | 78篇 |
1985年 | 95篇 |
1984年 | 49篇 |
1983年 | 50篇 |
1982年 | 41篇 |
1981年 | 39篇 |
1980年 | 32篇 |
1979年 | 22篇 |
1978年 | 28篇 |
1977年 | 26篇 |
1976年 | 29篇 |
1975年 | 16篇 |
1974年 | 23篇 |
1973年 | 22篇 |
1967年 | 15篇 |
排序方式: 共有3549条查询结果,搜索用时 0 毫秒
1.
Ann McPherson 《British medical journal》2005,330(7489):465-467
2.
3.
4.
D. Birch M. Payne Y. Chia S. McPherson 《Annals of the Royal College of Surgeons of England》1995,77(3):185-187
The Forrest Report led to the introduction of the breast screening programme with the aim of reducing mortality from breast cancer. In 1989 a breast screening programme was introduced to the South Bucks District and now two cycles have been completed. The findings are of a high yield of good prognosis tumours 71% and 72%, respectively. These encouraging figures are reflected in a high response rate and with a fall in the incidence of non-screen-detected tumours. 相似文献
5.
Klim McPherson 《Statistics in medicine》1990,9(6):595-600
This paper reviews aspects of the development of sequential analysis of clinical trial data in medicine and suggests simple strategies for progress. The emphasis is on the pragmatic and ethical requirements of aspects of the design of phase III trials and in circumstances of genuine uncertainty characterized by much clinical experimentation. In particular consideration is given to the consequences of determining sample sizes from incorrect estimates of treatment effects. Armitage's work on sequential trials is traced to simple group sequential procedures based on repeated significance tests to minimize expected sample sizes in a wide class of experimental situations. 相似文献
6.
7.
Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats. 总被引:2,自引:0,他引:2
T Kuber Sampath Petra Simic Rebecca Sendak Natasa Draca Ann E Bowe Stephen O'Brien Susan C Schiavi John M McPherson Slobodan Vukicevic 《Journal of bone and mineral research》2007,22(6):849-859
We show the systemic administration of low levels of TSH increases bone volume and improves bone microarchitecture and strength in aged OVX rats. TSH's actions are mediated by its inhibitory effects on RANKL-induced osteoclast formation and bone resorption coupled with stimulatory effects on osteoblast differentiation and bone formation, suggesting TSH directly affects bone remodeling in vivo. INTRODUCTION: Thyroid-stimulating hormone (TSH) receptor haploinsufficient mice with normal circulating thyroid hormone levels have reduced bone mass, suggesting that TSH directly affects bone remodeling. We examined whether systemic TSH administration restored bone volume in aged ovariectomized (OVX) rats and influenced osteoclast formation and osteoblast differentiation in vitro. MATERIALS AND METHODS: Sprague-Dawley rats were OVX at 6 months, and TSH therapy was started immediately after surgery (prevention mode; n = 80) or 7 mo later (restoration mode; n = 152). Hind limbs and lumbar spine BMD was measured at 2- or 4-wk intervals in vivo and ex vivo on termination at 8-16 wk. Long bones were subjected to microCT, histomorphometric, and biomechanical analyses. The direct effect of TSH was examined in osteoclast and osteoblast progenitor cultures and established rat osteosarcoma-derived osteoblastic cells. Data were analyzed by ANOVA Dunnett test. RESULTS: In the prevention mode, low doses (0.1 and 0.3 microg) of native rat TSH prevented the progressive bone loss, and importantly, did not increase serum triiodothyroxine (T3) and thyroxine (T4) levels in aged OVX rats. In restoration mode, animals receiving 0.1 and 0.3 microg TSH had increased BMD (10-11%), trabecular bone volume (100-130%), trabecular number (25-40%), trabecular thickness (45-60%), cortical thickness (5-16%), mineral apposition and bone formation rate (200-300%), and enhanced mechanical strength of the femur (51-60%) compared with control OVX rats. In vitro studies suggest that TSH's action is mediated by its inhibitory effects on RANKL-induced osteoclast formation, as shown in hematopoietic stem cells cultivated from TSH-treated OVX rats. TSH also stimulates osteoblast differentiation, as shown by effects on alkaline phosphatase activity, osteocalcin expression, and mineralization rate. CONCLUSIONS: These results show for the first time that systemically administered TSH prevents bone loss and restores bone mass in aged OVX rats through both antiresorptive and anabolic effects on bone remodeling. 相似文献
8.
9.
10.